Susan E. Stuber
Cincinnati Children's Hospital Medical Center(US)
Publications by Year
Research Areas
Hemoglobinopathies and Related Disorders, Iron Metabolism and Disorders, Myeloproliferative Neoplasms: Diagnosis and Treatment, Blood groups and transfusion, Blood donation and transfusion practices
Most-Cited Works
- → Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial(2015)501 cited
- → Hydroxyurea for Children with Sickle Cell Anemia in Sub-Saharan Africa(2018)362 cited
- → Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial(2015)64 cited
- → Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub‐Saharan Africa(2018)39 cited
- → Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE): an open-label, phase 2 trial(2023)32 cited
- → Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa(2022)28 cited
- → Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1/2 trial(2024)17 cited
- → TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia(2015)17 cited
- → Hydroxyurea for Children and Adults with Hemoglobin SC Disease(2024)14 cited
- → EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia(2016)11 cited